BioAge Labs, Inc. (BIOA)

BioAge Labs Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Net Income	-62.16	-63.85	-39.72
Depreciation & Amortization	0.17	0.16	0.13
Share-Based Compensation	-	3.02	2.54
Other Operating Activities	14.27	23.31	0.87
Operating Cash Flow	-47.72	-37.36	-36.18
Capital Expenditures	-0.13	-0.17	-0.1
Change in Investments	-	-0.1	-
Investing Cash Flow	-0.13	-0.27	-0.1
Share Issuance / Repurchase	-	0	0.04
Debt Issued / Paid	-	34.94	2.46
Financing Cash Flow	164.56	34.94	2.5
Net Cash Flow	116.68	-2.69	-33.54
Free Cash Flow	-47.85	-37.53	-36.28

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).